What saxi omits:
Nordic countries are restricting the use of Moderna’s Covid vaccine. Here’s why
PUBLISHED FRI, OCT 8 202111:22 AM EDTUPDATED FRI, OCT 8 20214:07 PM EDT
KEY POINTS• The decision the three countries have made to limit the use of the Moderna vaccine centers around concerns it could be linked to cases of myocarditis, a condition where the heart muscle becomes inflamed.
• All three health authorities cited an
unpublished Nordic study, which had been sent to the European Medicines Agency for assessment, according to Reuters.
A spokesperson for Moderna was not immediately available for comment when contacted by CNBC. The company told Reuters that these are “typically mild cases and individuals tend to recover within a short time following standard treatment and rest.”
“The risk of myocarditis is substantially increased for those who contract COVID-19, and vaccination is the best way to protect against this,” the spokesperson added.
Benefits vs. risks
Despite the risks associated with the immunization for young men, THL’s Salminen said Thursday that it was still important for everyone who was eligible to receive two doses of a vaccine.
According to the U.S. Centers for Disease Control and Prevention, the known risks of Covid-19 and its potentially severe complications far outweigh the possibility of having a rare adverse reaction to a vaccination. That includes the potential risk of developing myocarditis.In August, a U.S. study found that
males between the ages of 12 and 17 — the demographic most likely to develop myocarditis — were six times more likely to suffer heart inflammation from being infected with Covid-19 than from being vaccinated against the virus.https://www.cnbc.com/2021/10/08/nordic-countries-are-restricting-the-use-of-modernas-covid-vaccine.html